Inventor
ARONIN NEIL
US28 patents
⚠️ This page may combine multiple inventors who share the name “ARONIN NEIL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV MASSACHUSETTS
26 patentsUS9809817B2Nov 7, 2017
Oligonucleotide compounds for targeting huntingtin mRNA
UNIV MASSACHUSETTS33 citations97
US11230713B2Jan 25, 2022
Oligonucleotide compounds for targeting huntingtin mRNA
UNIV MASSACHUSETTS13 citations94
US10774327B2Sep 15, 2020
Oligonucleotide compounds for targeting huntingtin mRNA
UNIV MASSACHUSETTS14 citations94
US10435688B2Oct 8, 2019
Oligonucleotide compounds for targeting huntingtin mRNA
UNIV MASSACHUSETTS15 citations94
US7947658B2May 24, 2011
RNA interference for the treatment of gain-of-function disorders
UNIV MASSACHUSETTS28 citations92
US11827882B2Nov 28, 2023
Modified oligonucleotides targeting SNPs
UNIV MASSACHUSETTS7 citations83
US11753638B2Sep 12, 2023
Conjugated oligonucleotides
UNIV MASSACHUSETTS7 citations82
US10633653B2Apr 28, 2020
Bioactive conjugates for oligonucleotide delivery
UNIV MASSACHUSETTS14 citations82
US10457940B2Oct 29, 2019
AAV treatment of Huntington's disease
UNIV MASSACHUSETTS5 citations82
US10513710B2Dec 24, 2019
Exosomal loading using hydrophobically modified oligonucleotides
UNIV MASSACHUSETTS5 citations81
US11299734B2Apr 12, 2022
RNA interference for the treatment of gain-of-function disorders
UNIV MASSACHUSETTS1 citations73
US10344277B2Jul 9, 2019
RNA interference for the treatment of gain-of-function disorders
UNIV MASSACHUSETTS1 citations73
US12173286B2Dec 24, 2024
Fully stabilized asymmetric siRNA
UNIV MASSACHUSETTS2 citations72
US11773392B2Oct 3, 2023
AAV treatment of Huntington's disease
UNIV MASSACHUSETTS1 citations71
US11046957B2Jun 29, 2021
AAV treatment of Huntington's disease
UNIV MASSACHUSETTS2 citations71
US11505807B2Nov 22, 2022
Exosomal loading using hydrophobically modified oligonucleotides
UNIV MASSACHUSETTS2 citations70
US10945955B2Mar 16, 2021
Artificial exosome composition and related methods
UNIV MASSACHUSETTS2 citations69
US9434943B2Sep 6, 2016
RNA interference for the treatment of gain-of-function disorders
UNIV MASSACHUSETTS2 citations63
US12522824B2Jan 13, 2026
AAV treatment of Huntington's disease
UNIV MASSACHUSETTS0 citations61
US12571004B2Mar 10, 2026
Exosomal loading using hydrophobically modified oligonucleotides
UNIV MASSACHUSETTS0 citations60
US12077755B2Sep 3, 2024
Bioactive conjugates for oligonucleotide delivery
UNIV MASSACHUSETTS0 citations59
US12024706B2Jul 2, 2024
Modified oligonucleotides targeting SNPs
UNIV MASSACHUSETTS1 citations59
US12023407B2Jul 2, 2024
Artificial exosome composition and related methods
UNIV MASSACHUSETTS0 citations58
US9914924B2Mar 13, 2018
Methods and compositions for treating neurological disease
UNIV MASSACHUSETTS1 citations42
US6602673B2Aug 5, 2003
Huntingtin-related therapeutics and bioassay
UNIV MASSACHUSETTS0 citations39
US12268755B2Apr 8, 2025
Allele-specific inactivation of mutant HTT via gene editing at coding region single nucleotide polymorphisms
UNIV MASSACHUSETTS0 citations38